Tanuja Chitnis
Tanuja Chitnis is an expert in Neurology at Brigham and Women's Hospital (United States). As of October 2026, ScienceLeadR ranks Tanuja Chitnis in the top 1% of experts worldwide for Multiple Sclerosis and Autoimmune Diseases. Tanuja Chitnis has authored 644 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 2 of them ongoing. SLR score: 2,213 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Immunology - Psychiatry - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 644
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Longitudinal stability of dietary intake patterns in pediatric-onset multiple sclerosis: A multicenter prospective cohort study. PMID 42697107 — sclerosis, multiple sclerosis, cohort studies, diet, vegetables | Mult Scler Relat Disord | 2026 | 0 |
| Comparative Effectiveness of Treatments for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. PMID 42842889 — sample size, oligodendroglia, myelin-oligodendrocyte glycoprotein, adrenal cortex hormones, immunosuppressive agents, maintenance, glycoproteins, therapeutics, neurology, immunoglobulins, intravenous | Neurology | 2026 | 1 |
| Impaired control of autoimmunity increases pediatric multiple sclerosis risk in EBNA-1-seropositives and -seronegatives. PMID 42821346 — cells, sclerosis, multiple sclerosis, killer cells, natural, herpesvirus 4, human, immunity, infections, autoimmunity | Proc Natl Acad Sci U S A | 2026 | 0 |
| Genome-wide association analyses highlight the neuronal contribution to multiple sclerosis susceptibility. PMID 42706309 — cells, sclerosis, multiple sclerosis, major histocompatibility complex, genome, genetics, medical | Nat Genet | 2026 | 0 |
| Knowledge graph-guided multiple sclerosis identification and therapeutic trend analysis: Real-world evidence from two large healthcare systems. PMID 42664299 — cells, sclerosis, multiple sclerosis, interferon-beta, prescriptions, algorithms, diagnosis, therapeutics | PLOS Digit Health | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Care in Multiple Sclerosis (MS) NCT07011914 — sclerosis, multiple sclerosis, research, physical exertion | N/A | Recruiting | 2025 |
| Nasal Foralumab in Patients With Non Active Secondary Progressive Multiple Sclerosis NCT06890923 — sclerosis, multiple sclerosis, multiple sclerosis, chronic progressive, neoplasms, neoplasm metastasis, secondary progressive multiple sclerosis | Phase 2 | Recruiting | 2025 |
LeadR Networks
Main global connection map